Skip to main content

Merkel Cell Carcinoma News

Related terms: cutaneous APUDoma, Primary Neuroendocrine Carcinoma of the Skin, trabecular carcinoma of the skin

AI Getting Better at Detecting Skin Cancer

FRIDAY, Nov. 3, 2023 – Artificial intelligence (AI) is increasingly accurate in detecting skin cancer, according to a study presented at the annual meeting of the European Academy of Dermatology and...

Summer Skin Care Tips for Those With Darker Skin

SUNDAY, July 16, 2023 – Dermatologist Dr. Caroline Opene is often asked if certain types of sun blocks are better for people with darker skin. Not necessarily, says the director of the University of...

FDA Approves Zynyz (retifanlimab-dlwr) for the Treatment of Metastatic or Recurrent Locally Advanced Merkel Cell Carcinoma (MCC)

WILMINGTON, Del.--(BUSINESS WIRE)--Mar. 22, 2023-- Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynyz (retifanlimab-dlwr), a humanized monoclonal...

FDA Approves Keytruda (pembrolizumab) for the Treatment of Patients with Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma

KENILWORTH, N.J.--(BUSINESS WIRE) December 19, 2018 --Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has...

FDA Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma

March 23, 2017 – The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Skin Cancer

Related drug support groups

Keytruda